HCPCS Level IIdrugActive
J0589
Inj daxibotulinumtoxina-lanm
BETOS: O1E
Effective: 2024-04-01
Referenced in 13 policies
Description
Injection, daxibotulinumtoxina-lanm, 1 unit
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Daxxify
Manufacturer
Revance Therapeutics, Inc.
HCPCS Dosage
1 UNIT
Billing Units
100.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.